Nifty

:

24631.30

Sensex

:

80597.66

11.95 (0.05%)
57.75 (0.07%)

Login

Nifty
Sensex

:
:

24631.30
80597.66

11.95 (0.05%)
57.75 (0.07%)

Medico Remedies Ltd.

Pharmaceuticals & Drugs

Rating :

61/99

BSE: 540937 | NSE: MEDICO

Watchlist

NSE BSE

41.16

14-Aug-2025

Open
High
Low
Previous Close

42.84
43.04
40.96
42.41

Volume
Traded Value (lacs)
52 Week High
52 Week Low

222796
9247820.15
79.83
36.5

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

341.06
34.08
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

353.80
N/A
5.48

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.51
4.28
2.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.73
22.44
8.75

PAT CAGR (%)

10 Years
5 Years
3 Years

24.47
31.26
11.70

P:E (Median)

8 Years
5 Years
3 Years

-
55.33
65.10

P:BV (Average)

8 Years
5 Years
3 Years

-
8.91
10.34

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
34.88
38.76

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 38.25 30.80 24.19% 41.30 41.32 -0.05% 39.49 29.77 32.65% 39.35 42.36 -7.11%
Expenses 35.43 27.99 26.58% 34.64 36.68 -5.56% 36.38 27.04 34.54% 36.94 39.28 -5.96%
EBITDA 2.83 2.81 0.71% 6.66 4.65 43.23% 3.11 2.73 13.92% 2.41 3.08 -21.75%
EBIDTM 7.39% 9.12% 16.13% 11.24% 7.88% 9.18% 6.14% 7.26%
Other Income 0.66 0.29 127.59% 0.29 0.58 -50.00% 1.43 0.27 429.63% 0.68 0.96 -29.17%
Interest 0.28 0.18 55.56% 0.49 0.25 96.00% 0.28 0.22 27.27% 0.21 0.18 16.67%
Depreciation 0.77 0.75 2.67% 0.77 0.74 4.05% 0.76 0.72 5.56% 0.75 0.71 5.63%
PBT 2.43 2.17 11.98% 5.70 4.25 34.12% 3.50 2.06 69.90% 2.13 3.14 -32.17%
Tax 0.62 0.60 3.33% 1.36 1.15 18.26% 0.88 0.62 41.94% 0.58 0.72 -19.44%
PAT 1.82 1.58 15.19% 4.34 3.10 40.00% 2.62 1.44 81.94% 1.56 2.43 -35.80%
PATM 4.75% 5.13% 10.51% 7.50% 6.63% 4.85% 3.95% 5.73%
EPS 0.22 0.19 15.79% 0.52 0.37 40.54% 0.32 0.17 88.24% 0.19 0.29 -34.48%

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 158.39 150.94 144.92 140.44 121.02 122.39 88.64 97.69 61.02 54.42 66.68 Net Sales Growth 9.80% 4.15% 3.19% 16.05% -1.12% 38.08% -9.26% 60.10% 12.13% -18.39% Cost Of Goods Sold 113.61 94.50 95.70 88.33 70.74 79.37 57.38 67.79 33.50 29.35 53.00 Gross Profit 44.78 56.44 49.22 52.11 50.29 43.02 31.25 29.90 27.52 25.07 13.68 GP Margin 28.27% 37.39% 33.96% 37.10% 41.56% 35.15% 35.25% 30.61% 45.10% 46.07% 20.52% Total Expenditure 143.39 136.52 132.01 130.96 113.69 117.15 85.80 94.93 57.54 50.41 63.03 Power & Fuel Cost - 2.92 2.55 2.47 2.29 1.91 1.83 1.73 1.42 1.05 0.00 % Of Sales - 1.93% 1.76% 1.76% 1.89% 1.56% 2.06% 1.77% 2.33% 1.93% 0% Employee Cost - 6.28 5.92 5.68 5.41 4.50 3.83 3.32 3.89 4.42 4.25 % Of Sales - 4.16% 4.09% 4.04% 4.47% 3.68% 4.32% 3.40% 6.37% 8.12% 6.37% Manufacturing Exp. - 22.10 20.88 22.36 23.00 18.02 15.00 16.03 13.73 11.00 0.00 % Of Sales - 14.64% 14.41% 15.92% 19.01% 14.72% 16.92% 16.41% 22.50% 20.21% 0% General & Admin Exp. - 3.93 2.07 1.97 2.12 2.38 2.20 1.49 1.33 1.49 5.77 % Of Sales - 2.60% 1.43% 1.40% 1.75% 1.94% 2.48% 1.53% 2.18% 2.74% 8.65% Selling & Distn. Exp. - 6.25 3.93 9.60 9.03 8.30 4.80 3.86 2.82 2.69 0.00 % Of Sales - 4.14% 2.71% 6.84% 7.46% 6.78% 5.42% 3.95% 4.62% 4.94% 0% Miscellaneous Exp. - 0.53 0.97 0.54 1.10 2.67 0.75 0.71 0.84 0.41 0.00 % Of Sales - 0.35% 0.67% 0.38% 0.91% 2.18% 0.85% 0.73% 1.38% 0.75% 0% EBITDA 15.01 14.42 12.91 9.48 7.33 5.24 2.84 2.76 3.48 4.01 3.65 EBITDA Margin 9.48% 9.55% 8.91% 6.75% 6.06% 4.28% 3.20% 2.83% 5.70% 7.37% 5.47% Other Income 3.06 3.27 2.13 4.09 2.03 1.03 2.10 1.90 0.91 0.36 0.24 Interest 1.26 1.16 0.82 0.75 0.66 0.92 1.06 0.98 1.52 1.33 0.85 Depreciation 3.05 3.03 2.88 2.72 2.22 1.65 1.66 1.51 1.00 1.05 1.18 PBT 13.76 13.50 11.33 10.10 6.48 3.70 2.22 2.18 1.87 1.99 1.87 Tax 3.44 3.41 3.04 2.86 1.67 1.11 0.58 0.60 0.65 0.06 0.74 Tax Rate 25.00% 25.26% 26.83% 28.32% 25.77% 30.00% 26.13% 27.52% 34.76% 3.55% 39.57% PAT 10.34 10.09 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 PAT before Minority Interest 10.34 10.09 8.29 7.24 4.81 2.59 1.63 1.57 1.22 1.63 1.13 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.53% 6.68% 5.72% 5.16% 3.97% 2.12% 1.84% 1.61% 2.00% 3.00% 1.69% PAT Growth 20.94% 21.71% 14.50% 50.52% 85.71% 58.90% 3.82% 28.69% -25.15% 44.25% EPS 1.25 1.22 1.00 0.87 0.58 0.31 0.20 0.19 0.15 0.20 0.14

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 62.47 52.37 43.84 36.57 32.46 29.87 28.24 26.67 16.37 14.74 Share Capital 16.60 16.60 16.60 16.60 4.15 4.15 4.15 4.15 3.20 1.60 Total Reserves 45.87 35.77 27.25 19.98 28.31 25.72 24.09 22.52 13.17 13.14 Non-Current Liabilities 0.37 1.26 2.08 2.50 5.21 4.92 2.63 2.55 10.93 4.39 Secured Loans 0.00 0.00 0.00 0.65 4.70 4.46 2.13 1.94 2.62 0.00 Unsecured Loans 0.25 0.25 0.25 0.25 0.25 0.25 0.25 0.25 8.22 3.70 Long Term Provisions 0.00 0.00 0.06 0.05 0.10 0.00 0.00 0.09 0.07 0.00 Current Liabilities 58.93 44.58 43.15 39.57 37.95 40.48 45.45 30.17 21.11 26.41 Trade Payables 34.71 31.51 30.99 27.10 25.35 26.40 32.52 17.52 11.88 15.36 Other Current Liabilities 6.71 3.43 1.79 1.57 4.32 6.95 2.66 2.97 1.23 0.61 Short Term Borrowings 13.59 6.50 7.85 9.06 8.11 7.12 10.27 9.69 7.90 10.10 Short Term Provisions 3.92 3.13 2.53 1.84 0.17 0.01 0.00 0.00 0.09 0.34 Total Liabilities 121.77 98.21 89.07 78.64 75.62 75.27 76.32 59.39 48.41 45.54 Net Block 21.29 21.49 21.83 18.03 15.31 12.55 12.27 6.63 6.84 7.09 Gross Block 44.09 41.34 38.80 32.39 28.89 24.36 22.43 15.37 14.57 13.77 Accumulated Depreciation 22.80 19.85 16.97 14.36 13.58 11.82 10.17 8.74 7.73 6.68 Non Current Assets 22.88 22.48 22.91 19.65 17.14 18.63 17.13 13.69 10.25 8.72 Capital Work in Progress 0.36 0.00 0.07 0.00 0.00 2.28 0.90 4.37 2.76 0.00 Non Current Investment 0.20 0.20 0.00 0.00 0.11 0.15 0.15 0.24 0.29 0.51 Long Term Loans & Adv. 0.95 0.61 0.85 1.54 1.72 3.59 3.77 2.46 0.36 1.10 Other Non Current Assets 0.08 0.18 0.16 0.07 0.00 0.06 0.05 0.00 0.00 0.01 Current Assets 98.89 75.73 66.17 59.01 58.48 56.64 59.18 45.69 38.16 36.83 Current Investments 1.45 1.36 1.27 0.00 1.06 0.00 0.00 0.00 0.00 0.00 Inventories 26.73 16.34 19.70 18.11 14.55 18.26 16.07 14.91 10.14 9.17 Sundry Debtors 57.18 49.63 36.09 30.39 27.42 23.89 29.07 17.01 18.12 19.54 Cash & Bank 1.09 0.18 0.91 2.34 2.83 1.42 0.61 0.81 0.71 0.66 Other Current Assets 12.44 0.43 0.29 0.38 12.62 13.07 13.43 12.96 9.19 7.46 Short Term Loans & Adv. 11.98 7.78 7.91 7.78 12.10 12.67 12.99 12.60 8.88 7.21 Net Current Assets 39.96 31.15 23.02 19.43 20.53 16.16 13.74 15.52 17.05 10.42 Total Assets 121.77 98.21 89.08 78.66 75.62 75.27 76.31 59.38 48.41 45.55

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 4.89 2.44 8.17 5.86 -11.31 0.97 4.94 5.10 -3.22 -3.73 PBT 13.50 11.33 10.10 6.48 3.68 2.22 2.18 1.87 1.69 1.87 Adjustment 2.44 3.53 2.71 2.52 2.57 2.14 1.86 2.15 2.46 1.94 Changes in Working Capital -7.25 -9.26 -2.15 -1.34 -16.63 -2.81 1.49 1.64 -6.56 -6.96 Cash after chg. in Working capital 8.69 5.60 10.66 7.66 -10.38 1.54 5.53 5.66 -2.42 -3.15 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -3.80 -3.17 -2.50 -1.79 -0.93 -0.54 -0.55 -0.55 -0.49 -0.58 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 -0.03 -0.04 -0.02 -0.32 0.00 Cash From Investing Activity -3.46 -2.68 -6.60 -1.76 -16.96 -3.08 -4.43 -4.98 -2.81 0.32 Net Fixed Assets -3.11 -2.47 -6.48 -3.50 -2.25 -3.31 -3.59 -2.41 -3.56 -0.30 Net Investments -0.09 -0.29 -1.27 1.17 -1.02 0.00 0.09 0.05 0.22 0.53 Others -0.26 0.08 1.15 0.57 -13.69 0.23 -0.93 -2.62 0.53 0.09 Cash from Financing Activity -0.52 -0.49 -1.82 -5.77 18.28 2.60 -0.55 -0.62 5.80 2.25 Net Cash Inflow / Outflow 0.91 -0.73 -0.25 -1.67 -9.99 0.48 -0.04 -0.50 -0.23 -1.17 Opening Cash & Equivalents 0.18 0.91 1.17 2.83 0.00 0.16 0.21 0.71 0.66 1.82 Closing Cash & Equivalent 1.09 0.18 0.91 1.17 -9.99 0.65 0.16 0.21 0.43 0.66

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 7.53 6.31 5.28 4.41 19.55 18.00 68.05 64.27 51.16 92.15 ROA 9.18% 8.85% 8.63% 6.24% 3.43% 2.15% 2.31% 2.26% 3.47% 2.78% ROE 17.58% 17.23% 18.01% 13.94% 8.31% 5.61% 5.72% 5.67% 10.47% 7.97% ROCE 21.65% 21.90% 21.88% 15.09% 10.13% 7.66% 7.79% 9.05% 9.39% 10.86% Fixed Asset Turnover 3.53 3.62 3.95 3.95 4.60 3.79 5.17 4.13 4.04 4.90 Receivable days 129.15 107.96 86.40 87.18 76.51 109.06 86.09 103.77 120.17 73.64 Inventory Days 52.07 45.38 49.13 49.25 48.92 70.69 57.88 74.02 61.63 47.46 Payable days 127.89 119.19 120.01 135.32 119.00 187.40 94.07 94.52 101.11 88.47 Cash Conversion Cycle 53.33 34.15 15.53 1.11 6.44 -7.66 49.90 83.26 80.69 32.63 Total Debt/Equity 0.22 0.13 0.18 0.29 0.46 0.46 0.48 0.47 1.18 0.94 Interest Cover 12.66 14.76 14.52 10.79 5.02 3.09 3.22 2.23 2.27 3.21

Top Investors:

Annual Reports:

News Update:

Medico Remedies commences work for new factory
16th May 2025, 09:24 AM

The proposed capacity is to be added within 2 years
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback